FindTrial
Sign In

A Clinical Research for stage IV non-small cell lung cancer patients with different target dose radiation therapy and segmentation

A Clinical Research for stage IV non-small cell lung cancer patients with different target dose radiation therapy and segmentation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009253
Enrollment
Unknown
Registered
2016-09-23
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Control group:dose of radiotherapy 50Gy/25F
Experimental group:dose of radiotherapy 40Gy/8F

Sponsors

Xinqiao Hospital, Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. histopathologically confirmed distant metastasis of stage IV non-small cell lung cancer, expected survival > 12 weeks; 2. Read and fully understand the patient notice subjects, signed informed consent; 3. aged between 18~70 years old, and Karnofsky performance status >70; 4. no prior radiation to the thorax, Basic normal lung function; 5. no pleural effusion and superior vena cava syndrome.

Exclusion criteria

Exclusion criteria: 1. Not signed informed consent; 2. The disease progression during radiotherapy, intolerance to radiotherapy.

Design outcomes

Primary

MeasureTime frame
radiotherapeutic effect;—

Secondary

MeasureTime frame
side effects;—

Countries

China

Contacts

Public ContactTianxiang Cui

Institute of Cancer Research of People's Liberation Army, Xinqiao Hospital, Third Military Medical University, Chongqing

cuiwenyou@163.com+86 13896135542

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026